Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

UK prime minister Boris Johnson recently announced a fuzzy blueprint for his “winter plan”, in which further lockdowns and compulsory mask-wearing were not being introduced but could not be ruled out. As an interdisciplinary researcher specialising in complex systems and health policy, it looks to me like the UK is on course for yet another yo-yo winter in which too few precautions are introduced too late, only after the exponential increase in cases and deaths become too dramatic to brush aside.

Unless the British public learns to live with (as opposed to keep dying of) COVID, this cycle could continue indefinitely.

Here’s an alternative blueprint:

1. We agree to take the virus seriously

We must acknowledge that this virus is wily, pernicious and deadly. While some people – including most of those who are fully vaccinated – experience only mild symptoms, significant numbers are hospitalised. COVID has a fatality rate ten times that of seasonal flu. With case numbers remaining high, this means over 1,000 COVID deaths a week in the UK.

Read the full article on The Conversation website, written by Professor Trish Greenhalgh, Nuffield Department of Primary Care Health Sciences.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.

Cathy Creswell, David Roberts, and Matthew Costa elected Fellows of Academy of Medical Sciences

Cathy Creswell, Professor of Developmental Clinical Psychology at the Departments of Psychiatry and Experimental Psychology, David Roberts, Professor of Haematology at the Radcliffe Department of Medicine and Consultant Haematologist, and Matthew Costa, Professor of Orthopaedic Trauma Surgery at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, have been elected Fellows of the Academy of Medical Sciences.

Susan Lea and Jordan Raff elected Fellows of the Royal Society

Many congratulations to Susan and Jordan for this prestigious honour, recognising their contributions to structural and centrosome biology, respectively

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.